Aspirin-Triggered Resolvin D1 Reduces Proliferation and the Neutrophil to Lymphocyte Ratio in a Mutant KRAS-Driven Lung Adenocarcinoma Model
Tumour-associated neutrophils (TANs) can support tumour growth by suppressing cytotoxic lymphocytes. AT-RvD1 is an eicosanoid that can antagonise neutrophil trafficking instigated by ALX/FPR2 ligands such as serum amyloid A (SAA). We aimed to establish whether SAA and ALOX5 expression associates wit...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/13/3224 |
id |
doaj-1f6ad663d34c4be7828852cf39ea4882 |
---|---|
record_format |
Article |
spelling |
doaj-1f6ad663d34c4be7828852cf39ea48822021-07-15T15:31:38ZengMDPI AGCancers2072-66942021-06-01133224322410.3390/cancers13133224Aspirin-Triggered Resolvin D1 Reduces Proliferation and the Neutrophil to Lymphocyte Ratio in a Mutant KRAS-Driven Lung Adenocarcinoma ModelAmanda Vannitamby0Mohamed I. Saad1Christian Aloe2Hao Wang3Beena Kumar4Ross Vlahos5Stavros Selemidis6Louis Irving7Daniel Steinfort8Brendan J. Jenkins9Steven Bozinovski10School of Health & Biomedical Sciences, RMIT University, Bundoora 3083, AustraliaCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton 3168, AustraliaSchool of Health & Biomedical Sciences, RMIT University, Bundoora 3083, AustraliaSchool of Health & Biomedical Sciences, RMIT University, Bundoora 3083, AustraliaDepartment of Anatomical Pathology, Monash Health, Clayton 3168, AustraliaSchool of Health & Biomedical Sciences, RMIT University, Bundoora 3083, AustraliaSchool of Health & Biomedical Sciences, RMIT University, Bundoora 3083, AustraliaDepartment of Respiratory Medicine, Royal Melbourne Hospital, Parkville 3050, AustraliaDepartment of Respiratory Medicine, Royal Melbourne Hospital, Parkville 3050, AustraliaCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton 3168, AustraliaSchool of Health & Biomedical Sciences, RMIT University, Bundoora 3083, AustraliaTumour-associated neutrophils (TANs) can support tumour growth by suppressing cytotoxic lymphocytes. AT-RvD1 is an eicosanoid that can antagonise neutrophil trafficking instigated by ALX/FPR2 ligands such as serum amyloid A (SAA). We aimed to establish whether SAA and ALOX5 expression associates with TANs and investigate the immunomodulatory actions of AT-RvD1 in vivo. MPO-positive neutrophils were quantified in tumour blocks from lung adenocarcinoma (<i>n</i> = 48) and control tissue (<i>n</i> = 20) by IHC. Tumour expression of SAA and ALOX5 were analysed by RTqPCR and an oncogenic <i>Kras<sup>G12D</sup></i> lung adenocarcinoma mouse model was used to investigate the in vivo efficacy of AT-RvD1 treatment. ALOX5 expression was markedly reduced in lung adenocarcinoma tumours. The SAA/ALOX5 ratio strongly correlated with TANs and was significantly increased in tumours harbouring an oncogenic <i>KRAS</i> mutation. AT-RvD1 treatment reduced tumour growth in <i>Kras<sup>G12D</sup></i> mice, which was accompanied by suppressed cellular proliferation within parenchymal lesions. In addition, AT-RvD1 significantly reduced the neutrophil to lymphocyte ratio (NLR), an established prognostic marker of poor survival in adenocarcinoma. This study identifies a novel molecular signature whereby elevated levels of SAA relative to ALOX5 favour accumulation of TANs. Furthermore, the ALOX5/5-LO enzymatic product, AT-RvD1, markedly reduced the NLR and suppressed tumour growth in <i>Kras<sup>G12D</sup></i> mice.https://www.mdpi.com/2072-6694/13/13/3224lung canceradenocarcinomaneutrophilsresolutioninflammationALOX5 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Amanda Vannitamby Mohamed I. Saad Christian Aloe Hao Wang Beena Kumar Ross Vlahos Stavros Selemidis Louis Irving Daniel Steinfort Brendan J. Jenkins Steven Bozinovski |
spellingShingle |
Amanda Vannitamby Mohamed I. Saad Christian Aloe Hao Wang Beena Kumar Ross Vlahos Stavros Selemidis Louis Irving Daniel Steinfort Brendan J. Jenkins Steven Bozinovski Aspirin-Triggered Resolvin D1 Reduces Proliferation and the Neutrophil to Lymphocyte Ratio in a Mutant KRAS-Driven Lung Adenocarcinoma Model Cancers lung cancer adenocarcinoma neutrophils resolution inflammation ALOX5 |
author_facet |
Amanda Vannitamby Mohamed I. Saad Christian Aloe Hao Wang Beena Kumar Ross Vlahos Stavros Selemidis Louis Irving Daniel Steinfort Brendan J. Jenkins Steven Bozinovski |
author_sort |
Amanda Vannitamby |
title |
Aspirin-Triggered Resolvin D1 Reduces Proliferation and the Neutrophil to Lymphocyte Ratio in a Mutant KRAS-Driven Lung Adenocarcinoma Model |
title_short |
Aspirin-Triggered Resolvin D1 Reduces Proliferation and the Neutrophil to Lymphocyte Ratio in a Mutant KRAS-Driven Lung Adenocarcinoma Model |
title_full |
Aspirin-Triggered Resolvin D1 Reduces Proliferation and the Neutrophil to Lymphocyte Ratio in a Mutant KRAS-Driven Lung Adenocarcinoma Model |
title_fullStr |
Aspirin-Triggered Resolvin D1 Reduces Proliferation and the Neutrophil to Lymphocyte Ratio in a Mutant KRAS-Driven Lung Adenocarcinoma Model |
title_full_unstemmed |
Aspirin-Triggered Resolvin D1 Reduces Proliferation and the Neutrophil to Lymphocyte Ratio in a Mutant KRAS-Driven Lung Adenocarcinoma Model |
title_sort |
aspirin-triggered resolvin d1 reduces proliferation and the neutrophil to lymphocyte ratio in a mutant kras-driven lung adenocarcinoma model |
publisher |
MDPI AG |
series |
Cancers |
issn |
2072-6694 |
publishDate |
2021-06-01 |
description |
Tumour-associated neutrophils (TANs) can support tumour growth by suppressing cytotoxic lymphocytes. AT-RvD1 is an eicosanoid that can antagonise neutrophil trafficking instigated by ALX/FPR2 ligands such as serum amyloid A (SAA). We aimed to establish whether SAA and ALOX5 expression associates with TANs and investigate the immunomodulatory actions of AT-RvD1 in vivo. MPO-positive neutrophils were quantified in tumour blocks from lung adenocarcinoma (<i>n</i> = 48) and control tissue (<i>n</i> = 20) by IHC. Tumour expression of SAA and ALOX5 were analysed by RTqPCR and an oncogenic <i>Kras<sup>G12D</sup></i> lung adenocarcinoma mouse model was used to investigate the in vivo efficacy of AT-RvD1 treatment. ALOX5 expression was markedly reduced in lung adenocarcinoma tumours. The SAA/ALOX5 ratio strongly correlated with TANs and was significantly increased in tumours harbouring an oncogenic <i>KRAS</i> mutation. AT-RvD1 treatment reduced tumour growth in <i>Kras<sup>G12D</sup></i> mice, which was accompanied by suppressed cellular proliferation within parenchymal lesions. In addition, AT-RvD1 significantly reduced the neutrophil to lymphocyte ratio (NLR), an established prognostic marker of poor survival in adenocarcinoma. This study identifies a novel molecular signature whereby elevated levels of SAA relative to ALOX5 favour accumulation of TANs. Furthermore, the ALOX5/5-LO enzymatic product, AT-RvD1, markedly reduced the NLR and suppressed tumour growth in <i>Kras<sup>G12D</sup></i> mice. |
topic |
lung cancer adenocarcinoma neutrophils resolution inflammation ALOX5 |
url |
https://www.mdpi.com/2072-6694/13/13/3224 |
work_keys_str_mv |
AT amandavannitamby aspirintriggeredresolvind1reducesproliferationandtheneutrophiltolymphocyteratioinamutantkrasdrivenlungadenocarcinomamodel AT mohamedisaad aspirintriggeredresolvind1reducesproliferationandtheneutrophiltolymphocyteratioinamutantkrasdrivenlungadenocarcinomamodel AT christianaloe aspirintriggeredresolvind1reducesproliferationandtheneutrophiltolymphocyteratioinamutantkrasdrivenlungadenocarcinomamodel AT haowang aspirintriggeredresolvind1reducesproliferationandtheneutrophiltolymphocyteratioinamutantkrasdrivenlungadenocarcinomamodel AT beenakumar aspirintriggeredresolvind1reducesproliferationandtheneutrophiltolymphocyteratioinamutantkrasdrivenlungadenocarcinomamodel AT rossvlahos aspirintriggeredresolvind1reducesproliferationandtheneutrophiltolymphocyteratioinamutantkrasdrivenlungadenocarcinomamodel AT stavrosselemidis aspirintriggeredresolvind1reducesproliferationandtheneutrophiltolymphocyteratioinamutantkrasdrivenlungadenocarcinomamodel AT louisirving aspirintriggeredresolvind1reducesproliferationandtheneutrophiltolymphocyteratioinamutantkrasdrivenlungadenocarcinomamodel AT danielsteinfort aspirintriggeredresolvind1reducesproliferationandtheneutrophiltolymphocyteratioinamutantkrasdrivenlungadenocarcinomamodel AT brendanjjenkins aspirintriggeredresolvind1reducesproliferationandtheneutrophiltolymphocyteratioinamutantkrasdrivenlungadenocarcinomamodel AT stevenbozinovski aspirintriggeredresolvind1reducesproliferationandtheneutrophiltolymphocyteratioinamutantkrasdrivenlungadenocarcinomamodel |
_version_ |
1721299878684917760 |